Home/Filings/4/0001062993-23-001037
4//SEC Filing

Snow Ellen 4

Accession 0001062993-23-001037

CIK 0001835567other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 5:02 PM ET

Size

7.0 KB

Accession

0001062993-23-001037

Insider Transaction Report

Form 4
Period: 2023-01-14
Snow Ellen
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-14+20,32031,345 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-01-1420,32041,256 total
    Common Stock (20,320 underlying)
Footnotes (3)
  • [F1]Includes 11,025 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 30, 2022.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
  • [F3]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.

Issuer

Pear Therapeutics, Inc.

CIK 0001835567

Entity typeother

Related Parties

1
  • filerCIK 0001786643

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:02 PM ET
Size
7.0 KB